Table 3.
Motivations for buprenorphine diversion in the united States, by category, and total number of articles presenting evidence for each category1.
| First author, date | Avoid withdrawal symptoms | Self-treatment of OUD | To get high | Management of drug use and effects | Unable or difficult to procure drug of choice |
|---|---|---|---|---|---|
| Allen & Harocopos, 2016 | X | X | X | X | |
| Bazazi et al., 2011 | X | X | X | X | X |
| Brown & Altice, 2014 | X | X | |||
| Carlson et al., 2020 | X | ||||
| Carroll et al., 2018 | X | X | X | X | X |
| Cicero et al., 2014 | X | X | X | X | X |
| Cicero et al., 2018 | X | X | X | X | X |
| Daniulaityte et al., 2012 | X | X | X | X | X |
| Daniulaityte et al., 2015 | X | X | |||
| Daniulaityte et al., 2019 | X | X | |||
| Genberg et al., 2013 | X | X | X | ||
| Gryczynski et al., 2013 | X | X | |||
| Mitchell et. al., 2009 | X | X | X | ||
| Kavanaugh & McLean, 2020 | X | X | X | X | X |
| McLean & Kavanaugh, 2019 | X | X | |||
| Monico et al., 2015 | X | X | |||
| Monico et al., 2021 | X | X | X | ||
| Monte et al., 2009 | X | X | |||
| Schuman-Olivier et al., 2010 | X | ||||
| Silverstein et al., 2019 | X | X | X | X | |
| Silverstein et al., 2020 | X | ||||
| Smith et al., 2020 | X | ||||
| Sohler et al., 2013 | X | X | X | ||
| Tsui et al., 2018 | X | X | |||
| Walker et al., 2018 | X | X | |||
| Wish et al., 2012 | X | X | |||
| Total number of studies | 20 | 18 | 13 | 12 | 11 |